Apraglutide Reduces Parenteral Support Dependency in Patients with SBS-IF, CIC

Final data from STARS Nutrition were presented at United European Gastroenterology Week 2023, demonstrating a significant reduction in parenteral support.

Related Keywords

Linkedin Tim Vanuytsel ,Tim Vanuytsel ,Ironwood Pharmaceuticals Presents Positive Final Data ,Transplantation Center ,Ironwood Pharmaceuticals ,United European Gastroenterology Week ,Leuven Intestinal Failure ,Short Bowel Syndrome ,Intestinal Failure ,United European Gastroenterology ,Vectivbio Reports Positive Interim Clinical Data ,Investigating Apraglutide ,Intestinal Failure Patients ,Balance Study ,Patients With ,Stars Nutrition ,Stars ,Phase 2 ,Study ,Trial ,Apraglutide ,Parenteral Support ,Sbs If ,Colon In Continuity ,Cic ,Glp 2 ,Receptor ,